Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Feb 28, 2021 11:30pm
200 Views
Post# 32683280

RE:RE:March /Aristotle

RE:RE:March /Aristotle

Q4 earnings are set for March 31. Q1 for May 17.  Aristotle is expected by end of q1. I wouldn't expect Tripp to wait until the last day. So many are expecting anytime between now and say the 16.  

Biden 1.9 billion Bill expected to be law by March 14 too

hoping for a covid update or covid release to generate some buzz before the big Aristotle announcement   


 

Melray wrote: Is it the consensus that Aristotle will be rolled out around same time a Q4 earning report?(coming soon) or was the statement of Aristotle's in Q1 roll-out tied to Q1 reporting?(expected June-July). Just looking for clarification. Thx

 

<< Previous
Bullboard Posts
Next >>